Intersect ENT Competitors and Similar CompaniesClear all
Lyra Therapeutics's competitors and similar companies include OptiNose.
 Lyra Therapeutics Lyra Therapeutics is a therapeutics company focused on the development of integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. | ||
Founding Date | Founding Date 2005 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Watertown, US HQ | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 34 | Employees 2048% decrease |
Valuation ($) | Valuation ($) 17.4 m | Valuation ($) 118.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $398k (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Net income | Net income ($28.9m) (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 59.5m | Total funding raised $ 120.5m |
For sources of this data, please see the company profile
View Company Profiles
OptiNose
HQ
Morrisville, US
Employees
204↓ 8% decrease
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company